The ovarian cancer diagnostics market is undergoing a significant transformation as healthcare providers increasingly prioritize accurate disease identification, genetic risk assessment, and personalized treatment planning. The global Ovarian Cancer Diagnostics Market was valued at USD 1.74 billion in 2024 and is projected to reach USD 3.11 billion by 2033, expanding at a CAGR of 6.73% from...
The global neurological biomarkers market is experiencing significant growth as healthcare providers, pharmaceutical companies, and research organizations increasingly recognize the importance of accurate disease detection and personalized treatment. Neurological Biomarkers Market help identify disease-related biological changes, assess disease progression, estimate patient risk, and monitor...
The global molecular diagnostics market is witnessing steady expansion as healthcare providers increasingly prioritize early disease detection, accurate diagnosis, and personalized treatment. The Molecular Diagnostics Market was valued at USD 18.8 billion in 2025 and is projected to increase from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033....
The global breast biopsy market was valued at USD 2.83 billion in 2025 and is projected to grow from USD 3.14 billion in 2026 to USD 7.12 billion by 2034 , recording a CAGR of 10.8% during 2026-2034 . North America dominated the market with a 38.6% share in 2025 , while Asia Pacific is expected to register the fastest CAGR of 9.18% .
Market Size (2025): USD 2.83 Billion
Market Size...
The companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...
The global Molecular Diagnostics Market size was valued at USD 18.8 billion in 2025 and is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. North America dominated the market with a 44.1% revenue share in 2025. The growth of the molecular diagnostics industry is driven by increasing...
The global central nervous system biomarkers market is experiencing steady growth due to the increasing prevalence of neurological disorders, rising demand for early disease diagnosis, expanding investments in precision medicine, and continuous advancements in biomarker discovery technologies. The global central nervous system biomarkers market size was valued at USD 6.01 billion in...
Non-Invasive Testing Revolutionizes Disease Detection and Monitoring
The healthcare industry is experiencing a major shift toward minimally invasive diagnostic technologies that enable faster, safer, and more accurate disease detection. Among these innovations, liquid biopsy has emerged as a groundbreaking approach that is transforming cancer diagnostics, treatment selection, and disease...
The global pancreatic cancer therapeutics and diagnostics market is witnessing substantial expansion as healthcare systems worldwide intensify efforts toward early diagnosis and advanced treatment solutions. According to the latest market analysis, the global pancreatic cancer therapeutics and diagnostics market was valued at USD 4.88 billion in 2025 and is projected to grow from USD 5.23...
The global Liquid Biopsy Market size was estimated at USD 13.60 billion in 2025 and is projected to reach USD 32.57 billion by 2033, growing at a CAGR of 11.52% from 2026 to 2033. The market is experiencing significant growth due to the rising prevalence of cancer worldwide, rapid advancements in cancer diagnostics, and the increasing preference for minimally invasive testing methods....
This report presents a detailed, data-driven analysis of the global Liquid Biopsy Market Size, Share & Growth Trend Analysis Report (2026 - 2035) size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business...
The global genetic testing market is undergoing rapid transformation as advances in genomics, precision medicine, and digital healthcare continue reshaping the healthcare industry. The market is estimated at USD 14.49 billion in 2025 and is projected to grow from USD 17.41 billion in 2026 to USD 77.64 billion by 2034, registering a remarkable CAGR of 20.55% during the forecast period...